

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 5.35906840 |
| 2 | central nervous system myelination (GO:0022010) | 5.09514190 |
| 3 | axon ensheathment in central nervous system (GO:0032291) | 5.09514190 |
| 4 | protein maturation by protein folding (GO:0022417) | 4.98594657 |
| 5 | proteasome assembly (GO:0043248) | 4.61370356 |
| 6 | fatty acid elongation (GO:0030497) | 4.56558998 |
| 7 | COPI coating of Golgi vesicle (GO:0048205) | 4.27670361 |
| 8 | Golgi transport vesicle coating (GO:0048200) | 4.27670361 |
| 9 | protein deneddylation (GO:0000338) | 4.09431065 |
| 10 | regulation of mitochondrial translation (GO:0070129) | 3.85285660 |
| 11 | cullin deneddylation (GO:0010388) | 3.76711605 |
| 12 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.62517613 |
| 13 | neuronal action potential propagation (GO:0019227) | 3.55862585 |
| 14 | protein complex biogenesis (GO:0070271) | 3.52682041 |
| 15 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.48551407 |
| 16 | NADH metabolic process (GO:0006734) | 3.37886900 |
| 17 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.31551652 |
| 18 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.29893424 |
| 19 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.29287617 |
| 20 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.25512477 |
| 21 | nuclear envelope reassembly (GO:0031468) | 3.25498148 |
| 22 | mitotic nuclear envelope reassembly (GO:0007084) | 3.25498148 |
| 23 | L-phenylalanine catabolic process (GO:0006559) | 3.24881660 |
| 24 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.24881660 |
| 25 | negative regulation of neurotransmitter transport (GO:0051589) | 3.23366813 |
| 26 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.23188830 |
| 27 | gamma-aminobutyric acid transport (GO:0015812) | 3.21128183 |
| 28 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.20554959 |
| 29 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.20554959 |
| 30 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.19295751 |
| 31 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.18959279 |
| 32 | protein targeting to mitochondrion (GO:0006626) | 3.18953470 |
| 33 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.16086613 |
| 34 | mannosylation (GO:0097502) | 3.15125167 |
| 35 | synaptic vesicle exocytosis (GO:0016079) | 3.13508213 |
| 36 | protein retention in ER lumen (GO:0006621) | 3.13132939 |
| 37 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.12309269 |
| 38 | hydrogen ion transmembrane transport (GO:1902600) | 3.11091406 |
| 39 | positive regulation of TOR signaling (GO:0032008) | 3.10784982 |
| 40 | platelet dense granule organization (GO:0060155) | 3.08785275 |
| 41 | positive regulation of mitochondrial fission (GO:0090141) | 3.06632437 |
| 42 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.05212039 |
| 43 | oxidative phosphorylation (GO:0006119) | 3.04285954 |
| 44 | myelination (GO:0042552) | 3.03622248 |
| 45 | establishment of protein localization to mitochondrion (GO:0072655) | 3.02839744 |
| 46 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.02122574 |
| 47 | negative regulation of ligase activity (GO:0051352) | 3.02122574 |
| 48 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.01867904 |
| 49 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.01381908 |
| 50 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.99828050 |
| 51 | NADH dehydrogenase complex assembly (GO:0010257) | 2.99828050 |
| 52 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.99828050 |
| 53 | ensheathment of neurons (GO:0007272) | 2.99740135 |
| 54 | axon ensheathment (GO:0008366) | 2.99740135 |
| 55 | neuron cell-cell adhesion (GO:0007158) | 2.98096812 |
| 56 | response to methylmercury (GO:0051597) | 2.97156029 |
| 57 | protein localization to mitochondrion (GO:0070585) | 2.96873891 |
| 58 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.90563944 |
| 59 | L-phenylalanine metabolic process (GO:0006558) | 2.90563944 |
| 60 | lipopolysaccharide metabolic process (GO:0008653) | 2.89231708 |
| 61 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.88751625 |
| 62 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.88281051 |
| 63 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.87262303 |
| 64 | glutamate secretion (GO:0014047) | 2.87120510 |
| 65 | regulation of cellular amine metabolic process (GO:0033238) | 2.85372201 |
| 66 | C-terminal protein lipidation (GO:0006501) | 2.81668960 |
| 67 | chaperone-mediated protein transport (GO:0072321) | 2.81310021 |
| 68 | cytochrome complex assembly (GO:0017004) | 2.79707092 |
| 69 | metallo-sulfur cluster assembly (GO:0031163) | 2.79055873 |
| 70 | iron-sulfur cluster assembly (GO:0016226) | 2.79055873 |
| 71 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.78983374 |
| 72 | proton transport (GO:0015992) | 2.78557077 |
| 73 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.77658821 |
| 74 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.77620774 |
| 75 | tricarboxylic acid cycle (GO:0006099) | 2.76936467 |
| 76 | hydrogen transport (GO:0006818) | 2.76747173 |
| 77 | presynaptic membrane assembly (GO:0097105) | 2.76411736 |
| 78 | protein neddylation (GO:0045116) | 2.75764811 |
| 79 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.75309243 |
| 80 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.75309243 |
| 81 | anterograde synaptic vesicle transport (GO:0048490) | 2.74551314 |
| 82 | positive regulation of ligase activity (GO:0051351) | 2.73643276 |
| 83 | cholesterol biosynthetic process (GO:0006695) | 2.72604861 |
| 84 | response to redox state (GO:0051775) | 2.72167799 |
| 85 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.70454161 |
| 86 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.70432012 |
| 87 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.70432012 |
| 88 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.70432012 |
| 89 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.69867892 |
| 90 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.69867892 |
| 91 | presynaptic membrane organization (GO:0097090) | 2.69839691 |
| 92 | oligosaccharide catabolic process (GO:0009313) | 2.68373571 |
| 93 | cell redox homeostasis (GO:0045454) | 2.67892470 |
| 94 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.67077027 |
| 95 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.66120905 |
| 96 | protein-cofactor linkage (GO:0018065) | 2.63116890 |
| 97 | base-excision repair, AP site formation (GO:0006285) | 2.62872506 |
| 98 | serine transport (GO:0032329) | 2.61832648 |
| 99 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.61780394 |
| 100 | purine nucleotide salvage (GO:0032261) | 2.61747655 |
| 101 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.61697760 |
| 102 | L-serine transport (GO:0015825) | 2.61315758 |
| 103 | respiratory electron transport chain (GO:0022904) | 2.61083923 |
| 104 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.59752895 |
| 105 | substantia nigra development (GO:0021762) | 2.59563703 |
| 106 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.58733137 |
| 107 | mitochondrial transport (GO:0006839) | 2.58184105 |
| 108 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.57941137 |
| 109 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.57941137 |
| 110 | synaptic vesicle maturation (GO:0016188) | 2.57874749 |
| 111 | transmission of nerve impulse (GO:0019226) | 2.57576413 |
| 112 | L-amino acid import (GO:0043092) | 2.57437598 |
| 113 | pyrimidine-containing compound salvage (GO:0008655) | 2.55519555 |
| 114 | pyrimidine nucleoside salvage (GO:0043097) | 2.55519555 |
| 115 | daunorubicin metabolic process (GO:0044597) | 2.54389999 |
| 116 | polyketide metabolic process (GO:0030638) | 2.54389999 |
| 117 | doxorubicin metabolic process (GO:0044598) | 2.54389999 |
| 118 | electron transport chain (GO:0022900) | 2.54348402 |
| 119 | purine-containing compound salvage (GO:0043101) | 2.54288207 |
| 120 | cellular potassium ion homeostasis (GO:0030007) | 2.53542710 |
| 121 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.52802482 |
| 122 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.51834716 |
| 123 | de novo protein folding (GO:0006458) | 2.51527696 |
| 124 | heme metabolic process (GO:0042168) | 2.51231720 |
| 125 | nucleotide transmembrane transport (GO:1901679) | 2.50748303 |
| 126 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.50638021 |
| 127 | very long-chain fatty acid metabolic process (GO:0000038) | 2.50438790 |
| 128 | amino acid salvage (GO:0043102) | 2.50179832 |
| 129 | L-methionine biosynthetic process (GO:0071265) | 2.50179832 |
| 130 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.48735612 |
| 131 | glycerophospholipid catabolic process (GO:0046475) | 2.47896139 |
| 132 | regulation of synaptic vesicle transport (GO:1902803) | 2.44199488 |
| 133 | sterol biosynthetic process (GO:0016126) | 2.43118575 |
| 134 | transferrin transport (GO:0033572) | 2.42992264 |
| 135 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.42274806 |
| 136 | neurotransmitter uptake (GO:0001504) | 2.40399531 |
| 137 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.39835322 |
| 138 | regulation of glutamate secretion (GO:0014048) | 2.37242439 |
| 139 | neurotransmitter secretion (GO:0007269) | 2.36315411 |
| 140 | neurotransmitter catabolic process (GO:0042135) | 2.34948506 |
| 141 | trivalent inorganic cation transport (GO:0072512) | 2.34818486 |
| 142 | ferric iron transport (GO:0015682) | 2.34818486 |
| 143 | acyl-CoA biosynthetic process (GO:0071616) | 2.34506429 |
| 144 | thioester biosynthetic process (GO:0035384) | 2.34506429 |
| 145 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.34396189 |
| 146 | glutamate receptor signaling pathway (GO:0007215) | 2.34308585 |
| 147 | creatine metabolic process (GO:0006600) | 2.33545456 |
| 148 | cerebellar granule cell differentiation (GO:0021707) | 2.32011718 |
| 149 | import into cell (GO:0098657) | 2.29600162 |
| 150 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.26910249 |
| 151 | oligodendrocyte differentiation (GO:0048709) | 2.25333250 |
| 152 | signal peptide processing (GO:0006465) | 2.25148167 |
| 153 | acidic amino acid transport (GO:0015800) | 2.25134918 |
| 154 | neuron-neuron synaptic transmission (GO:0007270) | 2.24828714 |
| 155 | neurotransmitter transport (GO:0006836) | 2.24771104 |
| 156 | amino acid import (GO:0043090) | 2.24371061 |
| 157 | negative regulation of protein localization to cell surface (GO:2000009) | 2.23853474 |
| 158 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.23025978 |
| 159 | ATP synthesis coupled proton transport (GO:0015986) | 2.23025978 |
| 160 | synaptic transmission, glutamatergic (GO:0035249) | 2.22041626 |
| 161 | adult walking behavior (GO:0007628) | 2.21628782 |
| 162 | neuron remodeling (GO:0016322) | 2.20656258 |
| 163 | cellular copper ion homeostasis (GO:0006878) | 2.18555601 |
| 164 | vocalization behavior (GO:0071625) | 2.17814736 |
| 165 | myelin maintenance (GO:0043217) | 2.17510590 |
| 166 | neuromuscular process controlling posture (GO:0050884) | 2.16851409 |
| 167 | L-glutamate transport (GO:0015813) | 2.16511515 |
| 168 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.16252521 |
| 169 | negative regulation of synaptic transmission (GO:0050805) | 2.15708753 |
| 170 | aldehyde catabolic process (GO:0046185) | 2.14515833 |
| 171 | peptidyl-cysteine modification (GO:0018198) | 2.14270636 |
| 172 | aromatic amino acid family catabolic process (GO:0009074) | 2.14051124 |
| 173 | protein localization to synapse (GO:0035418) | 2.13576985 |
| 174 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.13251537 |
| 175 | regulation of neurotransmitter levels (GO:0001505) | 2.11950314 |
| 176 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.10891495 |
| 177 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.09950025 |
| 178 | response to dietary excess (GO:0002021) | 2.09662148 |
| 179 | magnesium ion transport (GO:0015693) | 2.09620099 |
| 180 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.08841052 |
| 181 | glycosylceramide metabolic process (GO:0006677) | 2.08448464 |
| 182 | neuron recognition (GO:0008038) | 2.07785911 |
| 183 | pH reduction (GO:0045851) | 2.07271748 |
| 184 | regulation of vesicle fusion (GO:0031338) | 2.05736568 |
| 185 | phagosome maturation (GO:0090382) | 2.05198439 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.81168590 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.21733965 |
| 3 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 4.09710934 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.02604399 |
| 5 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.52554414 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.47664299 |
| 7 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.43538071 |
| 8 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.31404513 |
| 9 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.02356824 |
| 10 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.88950627 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.78631886 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.62616565 |
| 13 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.61754355 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.56864795 |
| 15 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.56453906 |
| 16 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.51284206 |
| 17 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.41053142 |
| 18 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.36719902 |
| 19 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.35161389 |
| 20 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.32581942 |
| 21 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.27733731 |
| 22 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.25308413 |
| 23 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.25223070 |
| 24 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.24877275 |
| 25 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.24459871 |
| 26 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.21327490 |
| 27 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.19109950 |
| 28 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.18955413 |
| 29 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.17784251 |
| 30 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.16172837 |
| 31 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.14414163 |
| 32 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.14368421 |
| 33 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.13964602 |
| 34 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.12783680 |
| 35 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.04687488 |
| 36 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.02469673 |
| 37 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.01037098 |
| 38 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.97719980 |
| 39 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.95820021 |
| 40 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.95820021 |
| 41 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.95173369 |
| 42 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.94811447 |
| 43 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.90872419 |
| 44 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.88240101 |
| 45 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.87842571 |
| 46 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.87761285 |
| 47 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.87643210 |
| 48 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87542833 |
| 49 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.83983607 |
| 50 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.82347198 |
| 51 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.80296627 |
| 52 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.76268373 |
| 53 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.76217897 |
| 54 | VDR_22108803_ChIP-Seq_LS180_Human | 1.75629530 |
| 55 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.73285663 |
| 56 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.72594357 |
| 57 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.71522480 |
| 58 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.70386144 |
| 59 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.68741918 |
| 60 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.66779010 |
| 61 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.66524355 |
| 62 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.65167752 |
| 63 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.64625253 |
| 64 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.64487488 |
| 65 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.63662065 |
| 66 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.60509431 |
| 67 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.60032383 |
| 68 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59646103 |
| 69 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.59615067 |
| 70 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.58852450 |
| 71 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.54885538 |
| 72 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.53211296 |
| 73 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.53199861 |
| 74 | P300_19829295_ChIP-Seq_ESCs_Human | 1.52958822 |
| 75 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.52623938 |
| 76 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.52417902 |
| 77 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.50297095 |
| 78 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.48555502 |
| 79 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.46040392 |
| 80 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.44411351 |
| 81 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.44293119 |
| 82 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.43761642 |
| 83 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.43391016 |
| 84 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.43008075 |
| 85 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.43008075 |
| 86 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.41565486 |
| 87 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.41419862 |
| 88 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.37632380 |
| 89 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.37072353 |
| 90 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.36950107 |
| 91 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.36498883 |
| 92 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.35693964 |
| 93 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.31365051 |
| 94 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31237729 |
| 95 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.30976095 |
| 96 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.30951559 |
| 97 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.29914149 |
| 98 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.29182116 |
| 99 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.28952802 |
| 100 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.27205944 |
| 101 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.27000256 |
| 102 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.26651575 |
| 103 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.26490952 |
| 104 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.25277545 |
| 105 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.25218675 |
| 106 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.24794088 |
| 107 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.23943812 |
| 108 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.23889377 |
| 109 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23168582 |
| 110 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.22290914 |
| 111 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.22035314 |
| 112 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21492216 |
| 113 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.21444858 |
| 114 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.21246509 |
| 115 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.18940929 |
| 116 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.17658688 |
| 117 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15181925 |
| 118 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14450771 |
| 119 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12445855 |
| 120 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11323738 |
| 121 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.10845507 |
| 122 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.10594078 |
| 123 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.10462231 |
| 124 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.09974208 |
| 125 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.09230178 |
| 126 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08024557 |
| 127 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.07880854 |
| 128 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.07359650 |
| 129 | AR_25329375_ChIP-Seq_VCAP_Human | 1.06402585 |
| 130 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.04820424 |
| 131 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.04001957 |
| 132 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03729223 |
| 133 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.03298464 |
| 134 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.02373109 |
| 135 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.01913583 |
| 136 | JUN_21703547_ChIP-Seq_K562_Human | 1.01149139 |
| 137 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.00414530 |
| 138 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.99875655 |
| 139 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.99182573 |
| 140 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.99182573 |
| 141 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.99178028 |
| 142 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.98772970 |
| 143 | STAT3_23295773_ChIP-Seq_U87_Human | 0.97351746 |
| 144 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.96472080 |
| 145 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.96043549 |
| 146 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.95744672 |
| 147 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.95473831 |
| 148 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95242711 |
| 149 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95152049 |
| 150 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.94626904 |
| 151 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.94293593 |
| 152 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.93960265 |
| 153 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.93881036 |
| 154 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93545866 |
| 155 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.91358185 |
| 156 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.91317063 |
| 157 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.91260924 |
| 158 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.91088011 |
| 159 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.90616604 |
| 160 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.90170486 |
| 161 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.88852581 |
| 162 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.88824901 |
| 163 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.88182291 |
| 164 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.87751480 |
| 165 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.87560928 |
| 166 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87532258 |
| 167 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.87352906 |
| 168 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.85509131 |
| 169 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.84981840 |
| 170 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.84899560 |
| 171 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.84823532 |
| 172 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.84359772 |
| 173 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.83838246 |
| 174 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.83587020 |
| 175 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.83371624 |
| 176 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.83118461 |
| 177 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.82919634 |
| 178 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82850527 |
| 179 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.82733669 |
| 180 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.81415060 |
| 181 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.81390203 |
| 182 | KDM2B_26808549_Chip-Seq_REH_Human | 0.81142494 |
| 183 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.80494734 |
| 184 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79767096 |
| 185 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.77744127 |
| 186 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75565023 |
| 187 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.75186468 |
| 188 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74148387 |
| 189 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.74007702 |
| 190 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.73857284 |
| 191 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.73639721 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 3.93073302 |
| 2 | MP0009840_abnormal_foam_cell | 3.79266507 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 3.49355526 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 3.11163550 |
| 5 | MP0006082_CNS_inflammation | 3.06777188 |
| 6 | MP0004270_analgesia | 2.90796609 |
| 7 | MP0004510_myositis | 2.90381742 |
| 8 | MP0000343_altered_response_to | 2.77790854 |
| 9 | MP0000920_abnormal_myelination | 2.76311274 |
| 10 | MP0003011_delayed_dark_adaptation | 2.62814548 |
| 11 | MP0003329_amyloid_beta_deposits | 2.62769268 |
| 12 | MP0003186_abnormal_redox_activity | 2.61596594 |
| 13 | MP0003635_abnormal_synaptic_transmissio | 2.59025435 |
| 14 | MP0002064_seizures | 2.57081130 |
| 15 | MP0003195_calcinosis | 2.56011115 |
| 16 | MP0009046_muscle_twitch | 2.51460049 |
| 17 | MP0002272_abnormal_nervous_system | 2.39295310 |
| 18 | MP0009745_abnormal_behavioral_response | 2.34052707 |
| 19 | MP0001727_abnormal_embryo_implantation | 2.24899674 |
| 20 | MP0003690_abnormal_glial_cell | 2.15367120 |
| 21 | MP0001542_abnormal_bone_strength | 2.14473980 |
| 22 | MP0002139_abnormal_hepatobiliary_system | 2.12276797 |
| 23 | MP0003122_maternal_imprinting | 2.02471748 |
| 24 | MP0004043_abnormal_pH_regulation | 2.01950256 |
| 25 | MP0002734_abnormal_mechanical_nocicepti | 1.99614760 |
| 26 | MP0001968_abnormal_touch/_nociception | 1.98811666 |
| 27 | MP0001486_abnormal_startle_reflex | 1.97814141 |
| 28 | MP0003806_abnormal_nucleotide_metabolis | 1.92126491 |
| 29 | MP0001905_abnormal_dopamine_level | 1.91390251 |
| 30 | MP0002063_abnormal_learning/memory/cond | 1.91003828 |
| 31 | MP0001440_abnormal_grooming_behavior | 1.86412581 |
| 32 | MP0001529_abnormal_vocalization | 1.86326141 |
| 33 | MP0001853_heart_inflammation | 1.85802908 |
| 34 | MP0005623_abnormal_meninges_morphology | 1.85053134 |
| 35 | MP0002572_abnormal_emotion/affect_behav | 1.84341803 |
| 36 | MP0005423_abnormal_somatic_nervous | 1.79810878 |
| 37 | MP0009764_decreased_sensitivity_to | 1.77333092 |
| 38 | MP0001501_abnormal_sleep_pattern | 1.77286705 |
| 39 | MP0002736_abnormal_nociception_after | 1.70803890 |
| 40 | MP0004142_abnormal_muscle_tone | 1.69853197 |
| 41 | MP0000604_amyloidosis | 1.68501061 |
| 42 | MP0002822_catalepsy | 1.67746952 |
| 43 | MP0008875_abnormal_xenobiotic_pharmacok | 1.63787240 |
| 44 | MP0005360_urolithiasis | 1.60353803 |
| 45 | MP0005551_abnormal_eye_electrophysiolog | 1.58153695 |
| 46 | MP0006054_spinal_hemorrhage | 1.57208371 |
| 47 | MP0004885_abnormal_endolymph | 1.52911005 |
| 48 | MP0002102_abnormal_ear_morphology | 1.52029004 |
| 49 | MP0002148_abnormal_hypersensitivity_rea | 1.52008781 |
| 50 | MP0001984_abnormal_olfaction | 1.51583814 |
| 51 | MP0005257_abnormal_intraocular_pressure | 1.51124931 |
| 52 | MP0002067_abnormal_sensory_capabilities | 1.50935449 |
| 53 | MP0003633_abnormal_nervous_system | 1.50302893 |
| 54 | MP0002735_abnormal_chemical_nociception | 1.50199492 |
| 55 | MP0003646_muscle_fatigue | 1.50122305 |
| 56 | MP0010386_abnormal_urinary_bladder | 1.48731691 |
| 57 | MP0001970_abnormal_pain_threshold | 1.47716123 |
| 58 | MP0002229_neurodegeneration | 1.46518230 |
| 59 | MP0006035_abnormal_mitochondrial_morpho | 1.45931256 |
| 60 | MP0002733_abnormal_thermal_nociception | 1.45818882 |
| 61 | MP0005058_abnormal_lysosome_morphology | 1.44969323 |
| 62 | MP0000013_abnormal_adipose_tissue | 1.43364816 |
| 63 | MP0003191_abnormal_cellular_cholesterol | 1.42728187 |
| 64 | MP0006276_abnormal_autonomic_nervous | 1.41666729 |
| 65 | MP0003634_abnormal_glial_cell | 1.41238571 |
| 66 | MP0005646_abnormal_pituitary_gland | 1.39814680 |
| 67 | MP0005408_hypopigmentation | 1.39803171 |
| 68 | MP0002877_abnormal_melanocyte_morpholog | 1.39773525 |
| 69 | MP0005085_abnormal_gallbladder_physiolo | 1.39393089 |
| 70 | MP0005332_abnormal_amino_acid | 1.38810405 |
| 71 | MP0009785_altered_susceptibility_to | 1.37048436 |
| 72 | MP0003786_premature_aging | 1.34698491 |
| 73 | MP0002876_abnormal_thyroid_physiology | 1.34354468 |
| 74 | MP0004924_abnormal_behavior | 1.32159825 |
| 75 | MP0005386_behavior/neurological_phenoty | 1.32159825 |
| 76 | MP0008569_lethality_at_weaning | 1.30692531 |
| 77 | MP0002090_abnormal_vision | 1.30246093 |
| 78 | MP0004147_increased_porphyrin_level | 1.29871140 |
| 79 | MP0003121_genomic_imprinting | 1.29639297 |
| 80 | MP0003631_nervous_system_phenotype | 1.27864364 |
| 81 | MP0005165_increased_susceptibility_to | 1.27079191 |
| 82 | MP0000751_myopathy | 1.26975656 |
| 83 | MP0001502_abnormal_circadian_rhythm | 1.26213556 |
| 84 | MP0000358_abnormal_cell_content/ | 1.25496381 |
| 85 | MP0004742_abnormal_vestibular_system | 1.24935711 |
| 86 | MP0005645_abnormal_hypothalamus_physiol | 1.22980501 |
| 87 | MP0003172_abnormal_lysosome_physiology | 1.22196058 |
| 88 | MP0005171_absent_coat_pigmentation | 1.20814408 |
| 89 | MP0005083_abnormal_biliary_tract | 1.17932066 |
| 90 | MP0002066_abnormal_motor_capabilities/c | 1.16126963 |
| 91 | MP0005535_abnormal_body_temperature | 1.15979990 |
| 92 | MP0009780_abnormal_chondrocyte_physiolo | 1.15950066 |
| 93 | MP0005365_abnormal_bile_salt | 1.15410318 |
| 94 | MP0000750_abnormal_muscle_regeneration | 1.14427056 |
| 95 | MP0001756_abnormal_urination | 1.13450913 |
| 96 | MP0005164_abnormal_response_to | 1.12225929 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 1.10933042 |
| 98 | MP0003279_aneurysm | 1.10387634 |
| 99 | MP0004233_abnormal_muscle_weight | 1.09294814 |
| 100 | MP0005319_abnormal_enzyme/_coenzyme | 1.09173086 |
| 101 | MP0004272_abnormal_basement_membrane | 1.07492203 |
| 102 | MP0002909_abnormal_adrenal_gland | 1.07148728 |
| 103 | MP0003632_abnormal_nervous_system | 1.05967992 |
| 104 | MP0002332_abnormal_exercise_endurance | 1.05336894 |
| 105 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.03718716 |
| 106 | MP0001485_abnormal_pinna_reflex | 1.01342886 |
| 107 | MP0002882_abnormal_neuron_morphology | 1.01276522 |
| 108 | MP0000749_muscle_degeneration | 1.01207364 |
| 109 | MP0000778_abnormal_nervous_system | 1.00498669 |
| 110 | MP0000955_abnormal_spinal_cord | 1.00029600 |
| 111 | MP0009763_increased_sensitivity_to | 0.99551821 |
| 112 | MP0003950_abnormal_plasma_membrane | 0.97600854 |
| 113 | MP0003656_abnormal_erythrocyte_physiolo | 0.97227505 |
| 114 | MP0008469_abnormal_protein_level | 0.96226554 |
| 115 | MP0002118_abnormal_lipid_homeostasis | 0.95814362 |
| 116 | MP0002295_abnormal_pulmonary_circulatio | 0.95289019 |
| 117 | MP0002557_abnormal_social/conspecific_i | 0.94545064 |
| 118 | MP0006072_abnormal_retinal_apoptosis | 0.94433237 |
| 119 | MP0008789_abnormal_olfactory_epithelium | 0.93423843 |
| 120 | MP0002837_dystrophic_cardiac_calcinosis | 0.92080371 |
| 121 | MP0001533_abnormal_skeleton_physiology | 0.91826084 |
| 122 | MP0001666_abnormal_nutrient_absorption | 0.91356705 |
| 123 | MP0003075_altered_response_to | 0.90454849 |
| 124 | MP0009384_cardiac_valve_regurgitation | 0.89301519 |
| 125 | MP0002184_abnormal_innervation | 0.89260097 |
| 126 | MP0003879_abnormal_hair_cell | 0.87277210 |
| 127 | MP0005671_abnormal_response_to | 0.85721900 |
| 128 | MP0005636_abnormal_mineral_homeostasis | 0.85540214 |
| 129 | MP0000230_abnormal_systemic_arterial | 0.84906272 |
| 130 | MP0002638_abnormal_pupillary_reflex | 0.84112567 |
| 131 | MP0005379_endocrine/exocrine_gland_phen | 0.83849653 |
| 132 | MP0001963_abnormal_hearing_physiology | 0.82217719 |
| 133 | MP0005167_abnormal_blood-brain_barrier | 0.81973546 |
| 134 | MP0003941_abnormal_skin_development | 0.81377354 |
| 135 | MP0000372_irregular_coat_pigmentation | 0.80808783 |
| 136 | MP0001764_abnormal_homeostasis | 0.80439644 |
| 137 | MP0001765_abnormal_ion_homeostasis | 0.79870844 |
| 138 | MP0005084_abnormal_gallbladder_morpholo | 0.79763530 |
| 139 | MP0008260_abnormal_autophagy | 0.79437810 |
| 140 | MP0005595_abnormal_vascular_smooth | 0.78976322 |
| 141 | MP0001243_abnormal_dermal_layer | 0.78493773 |
| 142 | MP0001661_extended_life_span | 0.75835624 |
| 143 | MP0010329_abnormal_lipoprotein_level | 0.74478674 |
| 144 | MP0001177_atelectasis | 0.74433544 |
| 145 | MP0003868_abnormal_feces_composition | 0.74171316 |
| 146 | MP0001299_abnormal_eye_distance/ | 0.73535463 |
| 147 | MP0002069_abnormal_eating/drinking_beha | 0.72733572 |
| 148 | MP0008058_abnormal_DNA_repair | 0.72316268 |
| 149 | MP0006036_abnormal_mitochondrial_physio | 0.71881232 |
| 150 | MP0005410_abnormal_fertilization | 0.71028387 |
| 151 | MP0005451_abnormal_body_composition | 0.70745129 |
| 152 | MP0000858_altered_metastatic_potential | 0.70640194 |
| 153 | MP0002277_abnormal_respiratory_mucosa | 0.68975468 |
| 154 | MP0002933_joint_inflammation | 0.67229157 |
| 155 | MP0003137_abnormal_impulse_conducting | 0.66887145 |
| 156 | MP0001270_distended_abdomen | 0.66415029 |
| 157 | MP0009333_abnormal_splenocyte_physiolog | 0.66031291 |
| 158 | MP0008775_abnormal_heart_ventricle | 0.65365096 |
| 159 | MP0002060_abnormal_skin_morphology | 0.65180466 |
| 160 | MP0009643_abnormal_urine_homeostasis | 0.62939513 |
| 161 | MP0005390_skeleton_phenotype | 0.61321911 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.15161077 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.15161077 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 5.15161077 |
| 4 | Neurofibrillary tangles (HP:0002185) | 4.51257311 |
| 5 | Focal motor seizures (HP:0011153) | 3.92224089 |
| 6 | Myokymia (HP:0002411) | 3.56904577 |
| 7 | Vertebral compression fractures (HP:0002953) | 3.33029313 |
| 8 | Retinal dysplasia (HP:0007973) | 3.30433235 |
| 9 | Cerebral inclusion bodies (HP:0100314) | 3.27731807 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.19634519 |
| 11 | Pheochromocytoma (HP:0002666) | 3.08758358 |
| 12 | Supranuclear gaze palsy (HP:0000605) | 3.02643783 |
| 13 | Acute necrotizing encephalopathy (HP:0006965) | 3.02514097 |
| 14 | Increased muscle lipid content (HP:0009058) | 3.02470825 |
| 15 | Atonic seizures (HP:0010819) | 2.99806545 |
| 16 | Acute encephalopathy (HP:0006846) | 2.93231457 |
| 17 | Neuroendocrine neoplasm (HP:0100634) | 2.90850765 |
| 18 | Type I transferrin isoform profile (HP:0003642) | 2.89616386 |
| 19 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.84905760 |
| 20 | Cutaneous melanoma (HP:0012056) | 2.84770859 |
| 21 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.78663124 |
| 22 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.78663124 |
| 23 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.74456953 |
| 24 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.74365374 |
| 25 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.71222384 |
| 26 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.71222384 |
| 27 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.71222384 |
| 28 | Epileptic encephalopathy (HP:0200134) | 2.70615172 |
| 29 | Progressive macrocephaly (HP:0004481) | 2.68425139 |
| 30 | Mitochondrial inheritance (HP:0001427) | 2.65948992 |
| 31 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.65718120 |
| 32 | Generalized aminoaciduria (HP:0002909) | 2.65497273 |
| 33 | Dysmetria (HP:0001310) | 2.64362151 |
| 34 | Progressive neurologic deterioration (HP:0002344) | 2.62696656 |
| 35 | Abnormal glycosylation (HP:0012345) | 2.61573484 |
| 36 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.61573484 |
| 37 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.61573484 |
| 38 | Abnormal protein glycosylation (HP:0012346) | 2.61573484 |
| 39 | Hypokinesia (HP:0002375) | 2.54860840 |
| 40 | Hyperventilation (HP:0002883) | 2.54085348 |
| 41 | Scanning speech (HP:0002168) | 2.54027001 |
| 42 | Emotional lability (HP:0000712) | 2.51396249 |
| 43 | Spastic paraparesis (HP:0002313) | 2.50593807 |
| 44 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.48717244 |
| 45 | Mucopolysacchariduria (HP:0008155) | 2.48717244 |
| 46 | Sensory axonal neuropathy (HP:0003390) | 2.48161572 |
| 47 | Exercise intolerance (HP:0003546) | 2.47594287 |
| 48 | Cerebral hemorrhage (HP:0001342) | 2.46975149 |
| 49 | Hyperlipoproteinemia (HP:0010980) | 2.46843017 |
| 50 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.44355635 |
| 51 | Hepatocellular necrosis (HP:0001404) | 2.44120974 |
| 52 | Focal seizures (HP:0007359) | 2.41096289 |
| 53 | Increased serum lactate (HP:0002151) | 2.39784518 |
| 54 | Renal Fanconi syndrome (HP:0001994) | 2.39395980 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.38562031 |
| 56 | Dicarboxylic aciduria (HP:0003215) | 2.38562031 |
| 57 | Absence seizures (HP:0002121) | 2.36944259 |
| 58 | Abnormality of glycolysis (HP:0004366) | 2.35934217 |
| 59 | Increased serum pyruvate (HP:0003542) | 2.35934217 |
| 60 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.35338521 |
| 61 | Generalized tonic-clonic seizures (HP:0002069) | 2.28669445 |
| 62 | Anxiety (HP:0000739) | 2.28358188 |
| 63 | Dialeptic seizures (HP:0011146) | 2.27280103 |
| 64 | Abnormality of the anterior horn cell (HP:0006802) | 2.24850049 |
| 65 | Degeneration of anterior horn cells (HP:0002398) | 2.24850049 |
| 66 | Intention tremor (HP:0002080) | 2.24602118 |
| 67 | Progressive inability to walk (HP:0002505) | 2.23351487 |
| 68 | Beaking of vertebral bodies (HP:0004568) | 2.22873755 |
| 69 | Increased CSF lactate (HP:0002490) | 2.21612581 |
| 70 | Leukodystrophy (HP:0002415) | 2.21543771 |
| 71 | Hepatic necrosis (HP:0002605) | 2.21063373 |
| 72 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.20712983 |
| 73 | Spastic gait (HP:0002064) | 2.20491359 |
| 74 | Premature rupture of membranes (HP:0001788) | 2.19316888 |
| 75 | Parakeratosis (HP:0001036) | 2.19080584 |
| 76 | CNS demyelination (HP:0007305) | 2.18556378 |
| 77 | Type II lissencephaly (HP:0007260) | 2.18316840 |
| 78 | Visual hallucinations (HP:0002367) | 2.17324277 |
| 79 | Abnormality of the corticospinal tract (HP:0002492) | 2.14671130 |
| 80 | Xanthomatosis (HP:0000991) | 2.14161475 |
| 81 | Abnormality of macular pigmentation (HP:0008002) | 2.12216698 |
| 82 | Increased circulating renin level (HP:0000848) | 2.11807916 |
| 83 | Achilles tendon contracture (HP:0001771) | 2.11279909 |
| 84 | Opisthotonus (HP:0002179) | 2.11025162 |
| 85 | Cerebral edema (HP:0002181) | 2.10402495 |
| 86 | Generalized myoclonic seizures (HP:0002123) | 2.08948920 |
| 87 | Ragged-red muscle fibers (HP:0003200) | 2.08750544 |
| 88 | Action tremor (HP:0002345) | 2.08416494 |
| 89 | Progressive cerebellar ataxia (HP:0002073) | 2.08302065 |
| 90 | Prolonged neonatal jaundice (HP:0006579) | 2.05633913 |
| 91 | Lethargy (HP:0001254) | 2.04514204 |
| 92 | Intrahepatic cholestasis (HP:0001406) | 2.04283172 |
| 93 | Delayed gross motor development (HP:0002194) | 2.03838778 |
| 94 | Methylmalonic acidemia (HP:0002912) | 2.02370605 |
| 95 | Systemic lupus erythematosus (HP:0002725) | 2.00962201 |
| 96 | Abnormality of the Achilles tendon (HP:0005109) | 1.99837607 |
| 97 | Upper limb muscle weakness (HP:0003484) | 1.98744359 |
| 98 | Craniofacial dystonia (HP:0012179) | 1.98613571 |
| 99 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.97007696 |
| 100 | Focal dystonia (HP:0004373) | 1.96424420 |
| 101 | Nausea (HP:0002018) | 1.96280223 |
| 102 | Abnormal eating behavior (HP:0100738) | 1.95469226 |
| 103 | Sensorimotor neuropathy (HP:0007141) | 1.95083952 |
| 104 | Prolonged partial thromboplastin time (HP:0003645) | 1.93059762 |
| 105 | Loss of speech (HP:0002371) | 1.92563755 |
| 106 | Neoplasm of head and neck (HP:0012288) | 1.91907581 |
| 107 | Esophageal neoplasm (HP:0100751) | 1.91907581 |
| 108 | Clumsiness (HP:0002312) | 1.91648468 |
| 109 | Dysostosis multiplex (HP:0000943) | 1.90607480 |
| 110 | Metaphyseal dysplasia (HP:0100255) | 1.90390734 |
| 111 | Hypokalemic alkalosis (HP:0001949) | 1.90068788 |
| 112 | Hyperglycinemia (HP:0002154) | 1.88907642 |
| 113 | 3-Methylglutaconic aciduria (HP:0003535) | 1.88607135 |
| 114 | Hepatosplenomegaly (HP:0001433) | 1.88541215 |
| 115 | Peripheral hypomyelination (HP:0007182) | 1.87800345 |
| 116 | Delusions (HP:0000746) | 1.87682811 |
| 117 | Megalencephaly (HP:0001355) | 1.86641515 |
| 118 | Paraparesis (HP:0002385) | 1.86239436 |
| 119 | Ovoid vertebral bodies (HP:0003300) | 1.85663020 |
| 120 | Vacuolated lymphocytes (HP:0001922) | 1.85500204 |
| 121 | Methylmalonic aciduria (HP:0012120) | 1.84457178 |
| 122 | Exertional dyspnea (HP:0002875) | 1.82747969 |
| 123 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.82378636 |
| 124 | Sparse eyelashes (HP:0000653) | 1.82361746 |
| 125 | Increased hepatocellular lipid droplets (HP:0006565) | 1.82267020 |
| 126 | Ankle clonus (HP:0011448) | 1.81685630 |
| 127 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.81135424 |
| 128 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.81135424 |
| 129 | Respiratory failure (HP:0002878) | 1.81127104 |
| 130 | Febrile seizures (HP:0002373) | 1.80632549 |
| 131 | Split foot (HP:0001839) | 1.80317652 |
| 132 | Dysdiadochokinesis (HP:0002075) | 1.79899937 |
| 133 | Metabolic alkalosis (HP:0200114) | 1.78976957 |
| 134 | J-shaped sella turcica (HP:0002680) | 1.78259800 |
| 135 | Amyloidosis (HP:0011034) | 1.77514363 |
| 136 | Akinesia (HP:0002304) | 1.77470806 |
| 137 | Increased intramyocellular lipid droplets (HP:0012240) | 1.77167588 |
| 138 | Epileptiform EEG discharges (HP:0011182) | 1.76719963 |
| 139 | Optic disc pallor (HP:0000543) | 1.76143836 |
| 140 | Confusion (HP:0001289) | 1.75975171 |
| 141 | Abnormality of binocular vision (HP:0011514) | 1.75643533 |
| 142 | Diplopia (HP:0000651) | 1.75643533 |
| 143 | Cerebral hypomyelination (HP:0006808) | 1.75550544 |
| 144 | Cardiovascular calcification (HP:0011915) | 1.75383751 |
| 145 | Myoglobinuria (HP:0002913) | 1.74968401 |
| 146 | Rhabdomyolysis (HP:0003201) | 1.74953952 |
| 147 | Lipid accumulation in hepatocytes (HP:0006561) | 1.74915562 |
| 148 | Rough bone trabeculation (HP:0100670) | 1.74892539 |
| 149 | Psychosis (HP:0000709) | 1.74763334 |
| 150 | Polyphagia (HP:0002591) | 1.74392240 |
| 151 | Vascular calcification (HP:0004934) | 1.74331216 |
| 152 | Retinal atrophy (HP:0001105) | 1.73656874 |
| 153 | Slow saccadic eye movements (HP:0000514) | 1.73215725 |
| 154 | Autoamputation (HP:0001218) | 1.72500828 |
| 155 | Vomiting (HP:0002013) | 1.72399557 |
| 156 | Large eyes (HP:0001090) | 1.72220948 |
| 157 | EEG with generalized epileptiform discharges (HP:0011198) | 1.71939624 |
| 158 | Lactic acidosis (HP:0003128) | 1.71633660 |
| 159 | Termporal pattern (HP:0011008) | 1.71554653 |
| 160 | Insidious onset (HP:0003587) | 1.71554653 |
| 161 | Abnormal gallbladder physiology (HP:0012438) | 1.71213332 |
| 162 | Cholecystitis (HP:0001082) | 1.71213332 |
| 163 | Hypomagnesemia (HP:0002917) | 1.70887505 |
| 164 | X-linked dominant inheritance (HP:0001423) | 1.70252900 |
| 165 | Hyperammonemia (HP:0001987) | 1.70076225 |
| 166 | Thickened helices (HP:0000391) | 1.69863667 |
| 167 | Mitral stenosis (HP:0001718) | 1.69284983 |
| 168 | Axonal loss (HP:0003447) | 1.68613565 |
| 169 | Mutism (HP:0002300) | 1.68498265 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 3.89451552 |
| 2 | TESK1 | 3.79045694 |
| 3 | PIM2 | 3.74869989 |
| 4 | OXSR1 | 3.56488933 |
| 5 | NME2 | 3.17844868 |
| 6 | EPHA4 | 2.48539116 |
| 7 | NTRK3 | 2.43460796 |
| 8 | CDK19 | 2.26867277 |
| 9 | WNK4 | 2.20502224 |
| 10 | CASK | 2.15193863 |
| 11 | ARAF | 2.06773461 |
| 12 | TNIK | 2.06737677 |
| 13 | IRAK3 | 2.03860624 |
| 14 | NTRK1 | 1.98339578 |
| 15 | PDK2 | 1.96479391 |
| 16 | MAP4K2 | 1.90484505 |
| 17 | PBK | 1.85005645 |
| 18 | MAP2K7 | 1.76179777 |
| 19 | EIF2AK1 | 1.70422414 |
| 20 | BCR | 1.69382842 |
| 21 | SCYL2 | 1.65868035 |
| 22 | PNCK | 1.65764355 |
| 23 | PRPF4B | 1.61649694 |
| 24 | MYLK | 1.60817957 |
| 25 | CAMK2B | 1.59607467 |
| 26 | MAPKAPK5 | 1.57383249 |
| 27 | MAP3K12 | 1.56767458 |
| 28 | MAP3K4 | 1.49090410 |
| 29 | LIMK1 | 1.47425184 |
| 30 | MAP3K11 | 1.45128466 |
| 31 | MAPK15 | 1.42390574 |
| 32 | CAMK2D | 1.40217974 |
| 33 | KIT | 1.37231809 |
| 34 | MARK1 | 1.36422484 |
| 35 | CAMKK2 | 1.35790503 |
| 36 | MINK1 | 1.35663722 |
| 37 | RIPK4 | 1.34666223 |
| 38 | SGK494 | 1.32881374 |
| 39 | SGK223 | 1.32881374 |
| 40 | PKN1 | 1.31465599 |
| 41 | VRK2 | 1.26255116 |
| 42 | LMTK2 | 1.26251304 |
| 43 | INSRR | 1.25796629 |
| 44 | CSNK1G3 | 1.25031409 |
| 45 | CAMK2G | 1.24811695 |
| 46 | MAP3K9 | 1.24129812 |
| 47 | PAK4 | 1.23639255 |
| 48 | KDR | 1.22462386 |
| 49 | EPHB1 | 1.22024884 |
| 50 | FGFR2 | 1.20611548 |
| 51 | CAMK2A | 1.20117931 |
| 52 | BCKDK | 1.19427443 |
| 53 | CSNK1G2 | 1.18492049 |
| 54 | TGFBR2 | 1.18320283 |
| 55 | DAPK2 | 1.17990512 |
| 56 | TBK1 | 1.13714110 |
| 57 | NEK6 | 1.12856176 |
| 58 | CDK5 | 1.12028277 |
| 59 | GRK7 | 1.11667238 |
| 60 | NEK1 | 1.10359745 |
| 61 | ERN1 | 1.09450691 |
| 62 | WNK1 | 1.08970810 |
| 63 | BMPR2 | 1.05473091 |
| 64 | CSNK1A1L | 1.04968043 |
| 65 | MAP2K4 | 1.04848722 |
| 66 | UHMK1 | 1.03120319 |
| 67 | MAPKAPK3 | 1.02870902 |
| 68 | NME1 | 1.02618978 |
| 69 | PLK2 | 1.02278247 |
| 70 | PAK6 | 1.01529733 |
| 71 | MAP3K2 | 1.00482515 |
| 72 | GRK5 | 1.00463182 |
| 73 | STK16 | 1.00258555 |
| 74 | KSR2 | 0.99455359 |
| 75 | NTRK2 | 0.98866220 |
| 76 | TXK | 0.95588664 |
| 77 | MAP3K14 | 0.94009930 |
| 78 | IKBKB | 0.93887693 |
| 79 | TAOK2 | 0.93837250 |
| 80 | PAK3 | 0.93113971 |
| 81 | PRKCG | 0.91112372 |
| 82 | CDK14 | 0.90574264 |
| 83 | FES | 0.90316208 |
| 84 | PINK1 | 0.87282422 |
| 85 | MET | 0.87261192 |
| 86 | PRKCE | 0.86212386 |
| 87 | MAP3K5 | 0.85078105 |
| 88 | CSNK1G1 | 0.83930201 |
| 89 | IRAK1 | 0.83919426 |
| 90 | ABL2 | 0.83216352 |
| 91 | WNK3 | 0.82711208 |
| 92 | EPHA2 | 0.81719284 |
| 93 | PDPK1 | 0.80977473 |
| 94 | DDR2 | 0.80692124 |
| 95 | BUB1 | 0.78091809 |
| 96 | MAP3K3 | 0.77280501 |
| 97 | DAPK1 | 0.77054103 |
| 98 | MAP3K1 | 0.74929836 |
| 99 | PTK2B | 0.74831220 |
| 100 | SRPK1 | 0.74825220 |
| 101 | ROCK2 | 0.74589454 |
| 102 | EIF2AK3 | 0.73977967 |
| 103 | MAP3K13 | 0.73654194 |
| 104 | TAOK3 | 0.73366492 |
| 105 | BMPR1B | 0.72277783 |
| 106 | EPHB2 | 0.70493897 |
| 107 | IRAK2 | 0.69498251 |
| 108 | BRAF | 0.69484470 |
| 109 | CDK15 | 0.67715064 |
| 110 | ERBB4 | 0.66614902 |
| 111 | ILK | 0.66456672 |
| 112 | CDK18 | 0.66425201 |
| 113 | ERBB3 | 0.64820724 |
| 114 | AURKA | 0.64605282 |
| 115 | MUSK | 0.63702624 |
| 116 | PTK2 | 0.62741671 |
| 117 | CCNB1 | 0.60120111 |
| 118 | CAMKK1 | 0.60090698 |
| 119 | TRIM28 | 0.60036935 |
| 120 | DYRK3 | 0.57037548 |
| 121 | PHKG1 | 0.56883873 |
| 122 | PHKG2 | 0.56883873 |
| 123 | TNK2 | 0.56475604 |
| 124 | MST4 | 0.55987738 |
| 125 | CDK11A | 0.55231560 |
| 126 | IRAK4 | 0.55153773 |
| 127 | PRKCQ | 0.54989919 |
| 128 | PAK2 | 0.54864493 |
| 129 | DYRK1A | 0.54727426 |
| 130 | STK10 | 0.53928360 |
| 131 | CAMK1 | 0.51305689 |
| 132 | PAK1 | 0.51123398 |
| 133 | ADRBK2 | 0.50862305 |
| 134 | PDK1 | 0.50419086 |
| 135 | TESK2 | 0.50364235 |
| 136 | MAPK13 | 0.50309157 |
| 137 | DAPK3 | 0.49965671 |
| 138 | CSNK1A1 | 0.49287757 |
| 139 | FGR | 0.48598468 |
| 140 | PRKACA | 0.48187140 |
| 141 | ADRBK1 | 0.48066567 |
| 142 | PRKCI | 0.46850261 |
| 143 | PRKG1 | 0.46091363 |
| 144 | MOS | 0.45377193 |
| 145 | FER | 0.44576645 |
| 146 | RPS6KA5 | 0.44135858 |
| 147 | GRK1 | 0.42717617 |
| 148 | CSNK2A1 | 0.42661540 |
| 149 | CSNK2A2 | 0.40426486 |
| 150 | LRRK2 | 0.39036357 |
| 151 | DYRK2 | 0.38764365 |
| 152 | ABL1 | 0.36982872 |
| 153 | TAOK1 | 0.35865418 |
| 154 | MST1R | 0.33571377 |
| 155 | RAF1 | 0.33533663 |
| 156 | PRKG2 | 0.32594964 |
| 157 | SRC | 0.32354445 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.94161666 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.69092447 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.46529035 |
| 4 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.44732698 |
| 5 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.43232212 |
| 6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.16799622 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.16323542 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.15198988 |
| 9 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.15002269 |
| 10 | Protein export_Homo sapiens_hsa03060 | 2.11689863 |
| 11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.07788810 |
| 12 | Nicotine addiction_Homo sapiens_hsa05033 | 2.06610652 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.05411741 |
| 14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.03163178 |
| 15 | GABAergic synapse_Homo sapiens_hsa04727 | 1.92777564 |
| 16 | Parkinsons disease_Homo sapiens_hsa05012 | 1.84416579 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.77059097 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.74564434 |
| 19 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.74509380 |
| 20 | Alzheimers disease_Homo sapiens_hsa05010 | 1.72328534 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.70659660 |
| 22 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.63246332 |
| 23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.48464729 |
| 24 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.43392912 |
| 25 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.38934754 |
| 26 | Morphine addiction_Homo sapiens_hsa05032 | 1.37906830 |
| 27 | Sulfur relay system_Homo sapiens_hsa04122 | 1.35278444 |
| 28 | RNA polymerase_Homo sapiens_hsa03020 | 1.33978021 |
| 29 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.31628098 |
| 30 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.27295960 |
| 31 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.25627194 |
| 32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.24799985 |
| 33 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.24409419 |
| 34 | Circadian entrainment_Homo sapiens_hsa04713 | 1.24071096 |
| 35 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.23792734 |
| 36 | Ribosome_Homo sapiens_hsa03010 | 1.22988752 |
| 37 | Carbon metabolism_Homo sapiens_hsa01200 | 1.20297710 |
| 38 | Histidine metabolism_Homo sapiens_hsa00340 | 1.17672245 |
| 39 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.16070139 |
| 40 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.14895173 |
| 41 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.14618370 |
| 42 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.14217680 |
| 43 | Taste transduction_Homo sapiens_hsa04742 | 1.13317829 |
| 44 | Olfactory transduction_Homo sapiens_hsa04740 | 1.12181761 |
| 45 | Galactose metabolism_Homo sapiens_hsa00052 | 1.11996411 |
| 46 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.11978817 |
| 47 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.11928430 |
| 48 | Peroxisome_Homo sapiens_hsa04146 | 1.11491651 |
| 49 | Insulin secretion_Homo sapiens_hsa04911 | 1.11370154 |
| 50 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.11141456 |
| 51 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.08921057 |
| 52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.08587857 |
| 53 | Salivary secretion_Homo sapiens_hsa04970 | 1.07978799 |
| 54 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.07610297 |
| 55 | Long-term potentiation_Homo sapiens_hsa04720 | 1.04957520 |
| 56 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.01815762 |
| 57 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.01754738 |
| 58 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.01699094 |
| 59 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.00922820 |
| 60 | Huntingtons disease_Homo sapiens_hsa05016 | 0.99204181 |
| 61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.99190852 |
| 62 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.99086729 |
| 63 | Phototransduction_Homo sapiens_hsa04744 | 0.99027937 |
| 64 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.98835449 |
| 65 | Long-term depression_Homo sapiens_hsa04730 | 0.97542612 |
| 66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.96189900 |
| 67 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.95543765 |
| 68 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.94660534 |
| 69 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.93814730 |
| 70 | Lysosome_Homo sapiens_hsa04142 | 0.92821552 |
| 71 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.92688241 |
| 72 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.90298886 |
| 73 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.86191530 |
| 74 | Cocaine addiction_Homo sapiens_hsa05030 | 0.85939130 |
| 75 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.85757968 |
| 76 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.85724138 |
| 77 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.84672399 |
| 78 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.83859850 |
| 79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83108737 |
| 80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.81946056 |
| 81 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.81063133 |
| 82 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.80771655 |
| 83 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.80554067 |
| 84 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.79502912 |
| 85 | Bile secretion_Homo sapiens_hsa04976 | 0.79257297 |
| 86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.78945938 |
| 87 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.76767478 |
| 88 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.74907822 |
| 89 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73781682 |
| 90 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.71547313 |
| 91 | Renin secretion_Homo sapiens_hsa04924 | 0.68604646 |
| 92 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.67966955 |
| 93 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.67247901 |
| 94 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.66554777 |
| 95 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.65883322 |
| 96 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.64836655 |
| 97 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.64481395 |
| 98 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.64462325 |
| 99 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.63755274 |
| 100 | Phagosome_Homo sapiens_hsa04145 | 0.63413486 |
| 101 | Purine metabolism_Homo sapiens_hsa00230 | 0.61690371 |
| 102 | Shigellosis_Homo sapiens_hsa05131 | 0.61404471 |
| 103 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.61265787 |
| 104 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61110958 |
| 105 | Prion diseases_Homo sapiens_hsa05020 | 0.60215462 |
| 106 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.57824813 |
| 107 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.56994370 |
| 108 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55697577 |
| 109 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.54874552 |
| 110 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.54043227 |
| 111 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.53152955 |
| 112 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.53028739 |
| 113 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.52490846 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51222896 |
| 115 | Pertussis_Homo sapiens_hsa05133 | 0.51048800 |
| 116 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.50974054 |
| 117 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50466305 |
| 118 | Mineral absorption_Homo sapiens_hsa04978 | 0.50208596 |
| 119 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.50032901 |
| 120 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.49976996 |
| 121 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.48750624 |
| 122 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.48020409 |
| 123 | Salmonella infection_Homo sapiens_hsa05132 | 0.47097694 |
| 124 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.46813553 |
| 125 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45733806 |
| 126 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45571023 |
| 127 | Legionellosis_Homo sapiens_hsa05134 | 0.43079896 |
| 128 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43034838 |
| 129 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41107801 |
| 130 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.40438698 |
| 131 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.39885437 |
| 132 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.39645993 |
| 133 | Base excision repair_Homo sapiens_hsa03410 | 0.36186487 |
| 134 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.36129273 |
| 135 | Spliceosome_Homo sapiens_hsa03040 | 0.34482681 |
| 136 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.33855817 |
| 137 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.31343070 |
| 138 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.28119564 |
| 139 | Retinol metabolism_Homo sapiens_hsa00830 | 0.21512997 |
| 140 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.21458654 |

